Neurology News

Deep brain stimulation (DBS) therapy has been a safe and effective treatment option for Parkinson’s disease for more than 30 years, but another surgical option for the therapy has emerged.

For infants with Down syndrome, early intervention to address obstructive sleep apnea may lead to better cognitive and behavioral outcomes at 36 months, according to new research from The Lancet.

A federal judge has blocked the Federal Trade Commission’s ban on new noncompete agreements with all workers in for-profit organizations.

An Alabama-based company announced that the FDA has granted 510(k) clearance to its cyber device and AI system, which are designed to improve efficiency and accuracy of glioblastoma care.

Trust in health care diminished dramatically during the pandemic, and it will take multipronged interventions to restore that confidence, according to an expert.

A Vancouver-based biopharmaceutical company has secured a notice of allowance, presaging a U.S. patent for a crystalline formulation of a novel acetylcholinesterase inhibitor to treat Alzheimer’s disease.

Eyenavision and Avulux have launched Chemistrie Avulux, an eyeglass clip-on option for people with migraines and light sensitivity.

Use of nicardipine release implants during surgical aneurysm repair was safe, efficacious and led to better outcomes compared with standard care alone, according to research published in JAMA Neurology.

A Georgia-based biotechnology company has secured a U.S. patent for an exosome-based therapy to treat neuroinflammation that occurs in a range of neurodegenerative disease, according to the manufacturer.

In those with acute ischemic stroke, endovascular thrombectomy was associated with better overall outcomes at 12 months compared with standard medical treatment alone, according to research from The Lancet Neurology.